A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy
Public ClinicalTrials.gov record NCT02355158. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label, Single-arm Study to Evaluate the Long-term Use of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study CLO-311 is a multicenter, open-label, single-arm study to assess the long-term use of Clonidine Gel in the treatment of pain associated with PDN. Subjects who have completed their 12-week participation in Study CLO-290 or Study CLO-310 are eligible to rollover into this study and receive active study drug in an open-label manner.
Study identification
- NCT ID
- NCT02355158
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 197 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2014 (Type not available)
- Primary completion
- Aug 2015 (Actual)
- Completion
- Sep 2015 (Actual)
- Last update posted
- Sep 19, 2017
2014 – 2015
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85023 | — |
| Not listed | Santa Monica | California | 90404 | — |
| Not listed | Walnut Creek | California | 94598 | — |
| Not listed | Waterbury | Connecticut | 06708 | — |
| Not listed | Bradenton | Florida | 34205 | — |
| Not listed | Brandon | Florida | 33511 | — |
| Not listed | Jupiter | Florida | 33458 | — |
| Not listed | Miami | Florida | 33143 | — |
| Not listed | Tampa | Florida | 33606 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Columbus | Georgia | 31904 | — |
| Not listed | Kansas City | Kansas | 66160 | — |
| Not listed | Hazelwood | Missouri | 63042 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Warwick | Rhode Island | 02886 | — |
| Not listed | Dallas | Texas | 75230 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Houston | Texas | 77074 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Renton | Washington | 98507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02355158, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 19, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02355158 live on ClinicalTrials.gov.